REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

SCR 18 is a procedural resolution requesting Hawaii's Auditor to assess the social and financial effects of a proposed mandate requiring health insurance coverage for intravenous ketamine therapy to treat depression. This assessment is required by Hawaii law (HRS § 23-51) before the Legislature can consider Senate Bill 967, which proposes the coverage mandate. The Auditor must submit a report to the Legislature by a deadline set for the 2027 Regular Session to inform their decision on SB 967.